100 related articles for article (PubMed ID: 32413321)
1. Acquired 'Phase Separation' Underlies Aberrant Cell Fate Control?
Gao Y; Li P
Trends Biochem Sci; 2020 Jun; 45(6):457-458. PubMed ID: 32413321
[TBL] [Abstract][Full Text] [Related]
2. Impaired cell fate through gain-of-function mutations in a chromatin reader.
Wan L; Chong S; Xuan F; Liang A; Cui X; Gates L; Carroll TS; Li Y; Feng L; Chen G; Wang SP; Ortiz MV; Daley SK; Wang X; Xuan H; Kentsis A; Muir TW; Roeder RG; Li H; Li W; Tjian R; Wen H; Allis CD
Nature; 2020 Jan; 577(7788):121-126. PubMed ID: 31853060
[TBL] [Abstract][Full Text] [Related]
3. Hotspot mutations in the structured ENL YEATS domain link aberrant transcriptional condensates and cancer.
Song L; Yao X; Li H; Peng B; Boka AP; Liu Y; Chen G; Liu Z; Mathias KM; Xia L; Li Q; Mir M; Li Y; Li H; Wan L
Mol Cell; 2022 Nov; 82(21):4080-4098.e12. PubMed ID: 36272410
[TBL] [Abstract][Full Text] [Related]
4. Condensate-promoting ENL mutation drives tumorigenesis in vivo through dynamic regulation of histone modifications and gene expression.
Liu Y; Li Q; Song L; Gong C; Tang S; Budinich KA; Vanderbeck A; Mathias KM; Wertheim GB; Nguyen SC; Outen R; Joyce EF; Maillard I; Wan L
Cancer Discov; 2024 Apr; ():. PubMed ID: 38655899
[TBL] [Abstract][Full Text] [Related]
5. The interaction of ENL with PAF1 mitigates polycomb silencing and facilitates murine leukemogenesis.
Hetzner K; Garcia-Cuellar MP; Büttner C; Slany RK
Blood; 2018 Feb; 131(6):662-673. PubMed ID: 29217648
[TBL] [Abstract][Full Text] [Related]
6. The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin.
Zeisig DT; Bittner CB; Zeisig BB; García-Cuéllar MP; Hess JL; Slany RK
Oncogene; 2005 Aug; 24(35):5525-32. PubMed ID: 15856011
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure and function of chromatin regulated by "liquid-liquid phase separation" of biological macromolecules.
Gao XM; Zhang ZH
Yi Chuan; 2020 Jan; 42(1):45-56. PubMed ID: 31956096
[TBL] [Abstract][Full Text] [Related]
8. A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1.
Loizou E; Banito A; Livshits G; Ho YJ; Koche RP; Sánchez-Rivera FJ; Mayle A; Chen CC; Kinalis S; Bagger FO; Kastenhuber ER; Durham BH; Lowe SW
Cancer Discov; 2019 Jul; 9(7):962-979. PubMed ID: 31068365
[TBL] [Abstract][Full Text] [Related]
9. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
Rajasekhar VK; Begemann M
Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
[TBL] [Abstract][Full Text] [Related]
10. Aberrant chromatin remodeling in gynecological cancer.
Okawa R; Banno K; Iida M; Yanokura M; Takeda T; Iijima M; Kunitomi-Irie H; Nakamura K; Adachi M; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Oncol Lett; 2017 Nov; 14(5):5107-5113. PubMed ID: 29113150
[TBL] [Abstract][Full Text] [Related]
11. From start to end: Phase separation and transcriptional regulation.
Peng L; Li EM; Xu LY
Biochim Biophys Acta Gene Regul Mech; 2020 Dec; 1863(12):194641. PubMed ID: 33017669
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL).
Heidenreich D; Moustakim M; Schmidt J; Merk D; Brennan PE; Fedorov O; Chaikuad A; Knapp S
J Med Chem; 2018 Dec; 61(23):10929-10934. PubMed ID: 30407816
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification as an enabling mechanism for leukemic transformation.
Sollars VE
Front Biosci; 2005 May; 10():1635-46. PubMed ID: 15769653
[TBL] [Abstract][Full Text] [Related]
14. Altered primary chromatin structures and their implications in cancer development.
Ferraro A
Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278
[TBL] [Abstract][Full Text] [Related]
15. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell.
Zeisig BB; García-Cuéllar MP; Winkler TH; Slany RK
Oncogene; 2003 Mar; 22(11):1629-37. PubMed ID: 12642866
[TBL] [Abstract][Full Text] [Related]
16. Investigating the structural features of chromodomain proteins in the human genome and predictive impacts of their mutations in cancers.
Dahiya R; Naqvi AAT; Mohammad T; Alajmi MF; Rehman MT; Hussain A; Hassan MI
Int J Biol Macromol; 2019 Jun; 131():1101-1116. PubMed ID: 30917913
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Epigenetic Changes during Plant Regeneration.
Lee K; Seo PJ
Trends Plant Sci; 2018 Mar; 23(3):235-247. PubMed ID: 29338924
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic control of lymphocyte differentiation.
Lopez-Granados E
Adv Exp Med Biol; 2011; 711():26-35. PubMed ID: 21627040
[TBL] [Abstract][Full Text] [Related]
19. Activation of gene expression by histone deubiquitinase OTLD1.
Keren I; Citovsky V
Epigenetics; 2017 Jul; 12(7):584-590. PubMed ID: 28703681
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming.
Zardo G; Cimino G; Nervi C
Leukemia; 2008 Aug; 22(8):1503-18. PubMed ID: 18548105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
